Your browser doesn't support javascript.
loading
Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.
Matrana, Marc R; Bathala, Tharakeswara; Campbell, Matthew T; Duran, Cihan; Shetty, Aditya; Teegavarapu, Purnima; Kalra, Sarathi; Xiao, Lianchun; Atkinson, Bradley; Corn, Paul; Jonasch, Eric; Tannir, Nizar M.
Afiliação
  • Matrana MR; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bathala T; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Duran C; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shetty A; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Teegavarapu P; Hematology and Oncology Fellowship, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Kalra S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Xiao L; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Atkinson B; Division of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Corn P; Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jonasch E; Clinical Pharmacy Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BJU Int ; 118(2): 264-71, 2016 08.
Article em En | MEDLINE | ID: mdl-26573089
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Serina-Treonina Quinases TOR / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Serina-Treonina Quinases TOR / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article